Marbofloxacin-d8 (CAS 1185053-37-5)
QUICK LINKS
Marbofloxacin-d8′s mechanism of action involves inhibiting the bacterial DNA gyrase and topoisomerase IV enzymes, which are essential for DNA replication, transcription, and repair. By binding to these enzymes, marbofloxacin-d8 disrupts the normal cellular processes of bacteria, ultimately leading to the inhibition of bacterial growth and reproduction. Marbofloxacin-d8 interacts with the ATP-binding site of DNA gyrase and topoisomerase IV, preventing the enzymes from carrying out their functions. This interference with the enzymes′ activities results in the accumulation of double-stranded DNA breaks and the formation of abnormal DNA structures within the bacterial cells. As a consequence, the bacteria are unable to proliferate and are susceptible to the immune system or other antimicrobial agents. Marbofloxacin-d8 exerts its antibacterial effects by targeting and disrupting cellular enzymes involved in DNA metabolism, ultimately leading to the inhibition of bacterial replication and survival.
Marbofloxacin-d8 (CAS 1185053-37-5) References
- Marbofloxacin in equine medicine: have we got the doses right? | Lees, P. and Aliabadi, FS. 2002. Equine Vet J. 34: 322-5. PMID: 12117100
- Pharmacokinetics of enrofloxacin and marbofloxacin in Japanese quails and common pheasants. | Lashev, LD., et al. 2015. Br Poult Sci. 56: 255-61. PMID: 25567298
- Marbofloxacin-encapsulated microparticles provide sustained drug release for treatment of veterinary diseases. | Lee, J., et al. 2016. Mater Sci Eng C Mater Biol Appl. 60: 511-517. PMID: 26706558
- Tissue distribution of marbofloxacin in pigs after a single intramuscular injection. | Yang, F., et al. 2017. J Vet Sci. 18: 169-173. PMID: 27515270
- Pharmacokinetic-pharmacodynamic integration of marbofloxacin after single and repeated intravenous administration in goats. | Bhardwaj, P., et al. 2018. Res Vet Sci. 121: 111-115. PMID: 30384141
- Distribution of marbofloxacin in the bronchoalveolar region in healthy calves. | Hayashi, J., et al. 2019. J Vet Med Sci. 81: 730-733. PMID: 30918227
- The effects of Mannheimia haemolytica and albendazole on marbofloxacin pharmacokinetics in lambs. | Altan, F., et al. 2019. Trop Anim Health Prod. 51: 2603-2610. PMID: 31230255
- Rapid determination of marbofloxacin by surface-enhanced Raman spectroscopy of silver nanoparticles modified by β-cyclodextrin. | Zhao, R., et al. 2020. Spectrochim Acta A Mol Biomol Spectrosc. 229: 118009. PMID: 31927237
- Distribution of marbofloxacin within the bronchoalveolar region of healthy pigs. | Ijiri, M., et al. 2020. J Vet Med Sci. 82: 1080-1083. PMID: 32565495
- PK/PD Analysis of Marbofloxacin by Monte Carlo Simulation against Mycoplasmaagalactiae in Plasma and Milk of Lactating Goats after IV, SC and SC-Long Acting Formulations Administration. | Fernández-Varón, E., et al. 2021. Animals (Basel). 11: PMID: 33921496
- An Overview of Analytical Methods for the Quantification of Marbofloxacin in Pharmaceutical, Biological, and Food Matrixes. | da Silva, TLA., et al. 2022. J AOAC Int. 105: 456-462. PMID: 34718603
- Eco-Friendly UV Spectrophotometric Method for Evaluation of Marbofloxacin in Tablets: Stability Study. | da Silva, TLA., et al. 2022. J AOAC Int. 105: 1017-1022. PMID: 35148395
- Fast and new microbiological method for evaluating the potency of marbofloxacin-based tablets. | Ferreira, RGL., et al. 2022. J AOAC Int.. PMID: 36326443
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Marbofloxacin-d8, 500 µg | sc-218672 | 500 µg | $450.00 | |||
Marbofloxacin-d8, 1 mg | sc-218672-CW | 1 mg | $900.00 |